Naming a new drug is a complex process. The Pharma Marketing 411 hosts discuss the ins and outs, and the do’s and don’ts when it comes to naming drugs.
Nancy, our VP of Regulatory and Medication Safety, and Jennifer, our VP of Trademarks, discuss best practices for naming pharmaceuticals. The this two episode special, we have an in-depth conversation about our process and possible landmines to avoid when it comes to naming a new drug.
The Pharma Marketing 411 podcast interviews the life science industry’s most successful marketing professionals to gain actionable insights from those who are leading the way.